Goin Kathleen Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$785,987.84

Insider Activity of Goin Kathleen

According to the SEC Form 4 filings, Goin Kathleen, being in a position of

  1. Chief Operating Officer at Palvella Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 52157 shares for $6.12M,
    over all time since 2025-11-19, has bought 0 shares, and sold 52157 shares for $6.12M.

Biography of Goin Kathleen

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$6,120,56713100

Comparison of Insiders on Amount of Buys and Sells

2026-10-21SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
4,313
0.0295%
$124.58$537,307+15.46%
2026-09-16SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
4,302
0.0302%
$152.24$654,923-11.74%
2026-08-19SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
4,302
0.0304%
$152.21$654,791-2.59%
2026-07-15SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
4,302
0.0357%
$149.28$642,191-3.34%
2026-07-15SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
522
0.0043%
$147.14$76,805-3.34%
2026-06-17SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
4,302
0.0357%
$110.73$476,373+29.73%
2026-05-20SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
4,302
0.0348%
$110.56$475,631+23.46%
2026-04-15SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
4,302
0.036%
$127.24$547,399+7.35%
2026-03-18SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
4,302
0.0375%
$117.99$507,611+14.37%
2026-02-18SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
4,302
0.0363%
$79.40$341,564+65%
2026-01-21SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
4,302
0.0378%
$97.63$419,983+37.78%
2025-12-17SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
4,302
0.0361%
$96.47$415,023+38.12%
2025-11-19SalePalvella Therapeutics, Inc.
PVLA
Chief Operating Officer
4,302
0.0323%
$86.23$370,965+28.62%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.